Publications
- Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia - Czech national study2020 | First Faculty of Medicine
- Recommendations for the diagnosis and treatment of chronic lymphocytic leukaemia (CLL) - 20182018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Recommendations for the diagnosis and treatment of chronic lymphocytic leukaemia (CLL) Czech Group for Chronic Lymphocytic Leukaemia, section of the Czech Society of Haematology, CzMA2016 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients2015 | Faculty of Medicine in Hradec Králové
- Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients2015 | Publication without faculty affiliation
- Guidelines for alemtuzumab treatment in chronic lymphocytic leukemia (CLL)2012 | First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Minimal residual disease in chronic lymphocytic leukemia: Detection methods and clinical significance2010 | Third Faculty of Medicine
- Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders2008 | First Faculty of Medicine, Third Faculty of Medicine
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group2023 | Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
Loading network view...
